Slingshot Insights | Kis.f Overview

KIS.F Overview

Upcoming Projects (KIS.F)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (KIS.F)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (KIS.F)

Rigel Pharmaceuticals ($RIGL) Enters Collaboration and License Agreement with Kissei Pharmaceutical ($KIS.F) to Develop and Commercialize TAVALISSE (fostamatinib disodium hexahydrate) in Japan and other Asian Countries
Tickers: RIGL, KIS.F
Announcement Date: Oct 29, 2018